Biological importance of structurally diversified chromenes

M Costa, TA Dias, A Brito, F Proença - European journal of medicinal …, 2016 - Elsevier
Compounds incorporating the chromene scaffold are largely present in natural products and
display a wide variety of biological activities. Their low toxicity combined to the broad …

Current developments of coumarin compounds in medicinal chemistry

XM Peng, G LV Damu, H Zhou - Current pharmaceutical …, 2013 - ingentaconnect.com
Coumarin compounds represent an important type of naturally occurring and synthetic
oxygen-containing heterocycles with typical benzopyrone framework. This type of special …

Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins

A Maresca, C Temperini, L Pochet… - Journal of medicinal …, 2010 - ACS Publications
Coumarin derivatives were recently shown to constitute a totally new class of inhibitors of the
zinc metalloenzyme carbonic anhydrase (CA, EC 4.2. 1.1), being hydrolyzed within the CA …

Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment

G Stoll, C Kleinschnitz… - Blood, The Journal of the …, 2008 - ashpublications.org
In ischemic stroke, treatment options are limited. Therapeutic thrombolysis is restricted to the
first few hours after stroke, and the utility of current platelet aggregation inhibitors, including …

The antithrombotic activity of natural and synthetic coumarins

L Gao, F Wang, Y Chen, F Li, B Han, D Liu - Fitoterapia, 2021 - Elsevier
Thrombosis, which seriously endangers human health and life, is the leading cause of
morbidity and mortality globally. Antithrombotic drugs can interfere with the occurrence and …

[HTML][HTML] Synthetic coumarin derivatives with anticoagulation and antiplatelet aggregation inhibitory effects

TM Ramsis, MA Ebrahim, EA Fayed - Medicinal Chemistry Research, 2023 - Springer
Thrombosis is the leading cause of illness and mortality worldwide, posing a serious risk to
human health and life. Because antithrombotic drugs can prevent the beginning and …

Factor XII/XIIa inhibitors: Their discovery, development, and potential indications

C Davoine, C Bouckaert, M Fillet, L Pochet - European Journal of Medicinal …, 2020 - Elsevier
Coagulation factor XII (FXII), a S1A serine protease, was discovered more than fifty years
ago. However, its in vivo functions and its three-dimensional structure started to be disclosed …

Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins

F Chimenti, D Secci, A Bolasco… - Journal of medicinal …, 2009 - ACS Publications
A large series of 3-carboxamido-7-substituted coumarins have been synthesized and tested
in vitro for their human monoamine oxidase A and B (hMAO-A and hMAO-B) inhibitory …

Factor XI and XII as antithrombotic targets

F Müller, D Gailani, T Renne - Current opinion in hematology, 2011 - journals.lww.com
Hereditary deficiency of factor XII (Hageman factor) or factor XI, plasma proteases that
initiate the intrinsic pathway of coagulation, impairs thrombus formation and provides …

[PDF][PDF] A Multicomponent Coupling Reaction Induced by Insertion of Arynes into the C O Bond of Formamide

E Yoshioka, S Kohtani, H Miyabe - … Chemie International Edition, 2011 - academia.edu
Aryne compounds are highly reactive intermediates that have been widely used in organic
synthesis.[1, 2] In recent years, studies on aryne-based reactions have achieved some …